Member Info for researcher1

yep, just stay quiet for now - buy a few more if you can, wait for September. May be worth top slicing before Brexit (ha ha) even though a hard Brexit will give Costain a massive boost, as they are UK centred and it would wipe out even more of the competition...

bought £8K this morning - a great medium term play, as Costain, as a reliable firm, picks up contracts from Kier etc.
Autumn target 225

back in this morning at .95 - too good to miss. Ok there is political and financing uncertainty but gold is on the rise and surely Harry, however incompetent, is not a fool with his own cash, invested recently...

sold out this morning, but will no doubt be back in at some point. Nice profit, keep up the good work, thanks!

no, not telling porkies, so am as surprised as you, and have asked AN accordingly (will let you know) - I don't see this raise as a particular issue, as it will prevent sudden flutters if there are FDA delays (there often are though AN has been working closely with them so I hope not), but of course this has tempered SP predictions down from around £24 to £19. Let's hope it is the last one.

it will be from sales of Parsortix units (at, as I recall, around 80% profit per unit) with a forecast of the first stab at a multi billion dollar market (as the ONLY FDA approved liquid biopsy system). Yes, that's right, 80% of, say, £10 - 20 billion over 5 years. Let's say a CONSERVATIVE £7.5 billion then?! Hardly bears thinking about in terms of the current SP ( = x 40, so around £24 per share) - but institutions are not going to jump until all waters are smooth ahead - so after Jan 2019. Before then I'd expect a slow build to the £1.10 it hit when the prospect was first announced, for all those who daren't wait until the announcement. Afterwards, I'd want to be buy up to £10 per share, provided no competitors were on our tail. Happy Solstice!

I also don't think we've ever seen such a lukewarm reaction to such a major announcement!

will remain tight-lipped IMO. He knows that any word from CIR to support or spark the SP will simply be sold into by Woodford, so will wait with any good news on revenues (I feel there will already be some) for as long as possible, and support the climb once W has stopped selling.

I bought in today at 16.25 but I think there could be an even lower spot yet (so am saving from BCN profits some to top up with). Bears are in total control so it will only turn when they want it to - as there is no enthusiasm from small investors (except Pharma contrarians like us) because it smells of Woodford - not a good perfume 'pour aujourd'hui'. That said, I agree with RA1's general analysis - average valuation would put this at circa 65p. His trade analysis not so sharp - the 250K buy was timed earlier in the day and produced a small tick up at the time, which was eaten away by more selling later....

I'm also in Bacanora, so looks like party weekend...

make that £8K profit...

happy days

I appear to be £5K in profit suddenly - hurray for (slightly) discounted placings!

a 'slow build' like today over the next 2 months could get very interesting indeed...!

the pre-production value must be up around 80p per share, so plenty of room left?

I'm not sure how AN would feel about that - don't want to jeopardise the correspondence - I'll ask him. However, I'd urge you to approach him via email with your own questions - he was very direct and open about there being no need for funding and everything running to time scale, so I'm sure will be with you too.

very odd trading indeed this morning

may revise my opinion on the distressed seller idea - the 11.38 does look that way....

many are up 50% on AGL so possibly some profit taking, but the trades don't tell a 'distressed seller' story - I think it is being walked down 'for a rest' - and to let a few big buys go through. Revenues here are HUGE post-approval, so there's no way astute investors are going to wait for FDA news to get in...

doubt any sales as yet - the plan was always to wait for FDA approval first. Perhaps some research, fees and license payments though..?

nice reply from AN over the weekend, saying no need for any funding, everything panning out as planned except for a few nice surprises. His contempt for market not seeing the progress was heartening!